3

FORM 3 - ALLOGENE THERAPEUTICS, INC.

Company: Allogene Therapeutics, Inc.
Filed: January 21, 2022
Period of Report: January 12, 2022
Accession Number: 0001387131-22-000611

View Document ↗ View on SEC.gov ↗